Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany.
Joaquim
J
Bosch-Barrera
Ignacio
I
Gil-Bazo
D000911:Antibodies, Monoclonal / Q000191:economics*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000191:economics*; D005971:Glutamates / Q000191:economics*; D006147:Guanine / Q000031:analogs & derivatives*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000191:economics*
D000911:Antibodies, Monoclonal; D005971:Glutamates; D006147:Guanine